keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Neuronostatin-13 human acetate is a 13-amino acid peptide hormone, which plays an important role in the regulation of hormonal and cardiac function.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 203.00 | |
5 mg | Inquiry | $ 613.00 | |
10 mg | Inquiry | $ 921.00 | |
25 mg | Inquiry | $ 1,653.00 | |
50 mg | Inquiry | $ 2,479.00 | |
100 mg | Inquiry | $ 3,722.00 | |
200 mg | Inquiry | $ 5,598.00 |
Description | Neuronostatin-13 human acetate is a 13-amino acid peptide hormone, which plays an important role in the regulation of hormonal and cardiac function. |
In vitro | Treatment with Neuronostatin-13 human acetate (1,000 nM) enhances low-glucose-induced glucagon release compare with islets treated with control medium alone. Treatment with Neuronostatin-13 human acetate for 1 h leads to a significant increase in the accumulation of glucagon mRNA compare with vehicle-treated control cells. In αTC1-9 α-cells, treatment with 100 nM Neuronostatin-13 human acetate leads to an increase in phosphorylated PKA at 30 and 40 min[1]. |
In vivo | Infusion with Neuronostatin-13 human acetate delays glucose clearance in the rat model, such that blood glucose levels in Neuronostatin-13 human acetate-treated animals are significantly higher at 1 and 10 min following intra-arterial injection of a glucose bolus[1]. Chocardiographic measurement reveals a remarkable drop in heart rate after 3-, 6- and 12-hr of Neuronostatin-13 human acetate challenge. In addition, Neuronostatin-13 human acetate treatment significantly decreases left ventricular end-systolic diameter (LVESD) and fractional shortening without affecting left ventricular end-diastolic diameter (LVEDD) between 6 and 12 hrs following Neuronostatin-13 human acetate challenge, the effect of which returns to basal level 18-hr after Neuronostatin-13 human acetate treatment[2]. |
Synonyms | Neuronostatin-13 human acetate(1096485-24-3 free base) |
Molecular Weight | 1475.73 |
Formula | C66H114N20O18 |
CAS No. | TP1827L |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Neuronostatin-13 human acetate TP1827L Others Neuronostatin-13 human Acetate Neuronostatin 13 human acetate Neuronostatin-13 human acetate(1096485-24-3 free base) Neuronostatin13 human acetate inhibitor inhibit